AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2015
Oct 23, 2015
31565_dirs_2015-10-23_1edbcaee-22d2-4eea-bfad-039f2272c282.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-09-28
Reporting Person: Ryding Neil 122-62-507 (EVP, Global Manufacturing)
More from HAEMONETICS CORP
Annual Report
2026
May 20
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13